Skip to content ↓

News briefs

Bates milestone

At 8 a.m. on Tuesday, May 31, the 31-year use of the Bates Linear Accelerator as a national nuclear physics user facility under the sponsorship of the Office of Nuclear Physics of the U.S. Department of Energy came to an end. The Middleton, Mass., facility had been used by an international collaboration of scientists for frontier research in electromagnetic physics. Negotiations are in the final stages for transferring the Bates facility from DOE to MIT, which might use the accelerator for a new interdisciplinary center.

Animal care concerns

Vice President for Research and Associate Provost Alice Gast and the chairman of the Committee on Animal Care are once again soliciting any information that would aid MIT's effort to maintain the humane care of animals used in research.

The committee was established to ensure that all MIT researchers working with animals comply with federal, state, local and institutional regulations on animal care. To that end, it inspects animals, animal facilities and labs, and reviews all research and teaching exercises that involve animals before experiments are performed.

If you have information about inadequate animal care or any information that would help the committee fulfill its responsibilities, contact the committee at 253-9436 or call Gast at 253-1403. All concerns about animal care will be handled confidentially and will be investigated by the committee.

A version of this article appeared in MIT Tech Talk on June 1, 2005 (download PDF).

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story